# Oral Multiple-dose Study in Patients With Major Depressive Disorder

> **NCT01924520** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 32 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** FK949E

## Key facts

- **NCT ID:** NCT01924520
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01924520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01924520, "Oral Multiple-dose Study in Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01924520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*